BioSpace News Archive

Esperion (NASDAQ: ESPR) today announced the publication of data from a pooled analysis of patients enrolled in four Phase 3 bempedoic acid studies in the Journal of Clinical Lipidology.

Amedisys, Inc., a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for the first quarter ended March 31, 2022, after the market closes on April 27, 2022.

HTG Molecular Diagnostics, Inc., a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced it has expanded its therapeutics team with the addition of Christina M. Carruthers, Ph.D., an experienced program leader in drug discovery and development.

Aquestive Therapeutics, Inc. announced it has entered into a common stock purchase agreement for up to $40 million with Lincoln Park Capital Fund, LLC, a Chicago-based institutional investor.

ExCellThera Inc. announced today the publication of a scientific article entitled “ UM171 expansion of cord blood improves donor availability and HLA matching for all patients, including minorities ”.

HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), today announced positive preclinical data demonstrating potent T cell responses, potential novel combination use beyond PD-1 inhibitors, and the ability to break immune tolerance to various self-antigens for targeting cancers.

Akron Bio, a leading developer and manufacturer of critical building blocks used by biopharma to produce advanced therapies for the prevention and treatment of cardiovascular diseases and cancers, launched a new, state-of-the-art cGMP plasmid DNA manufacturing facility in Sarasota, Florida.

Astellas Pharma Inc. and Seagen Inc. announced that the European Commission has approved PADCEV™ as monotherapy for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and a PD-1/L1 inhibitor.

The Medical College of Wisconsin Cancer Center announced the appointment of several key leadership positions, reflecting a commitment to accelerate cancer research and address disparities in cancer incidence and outcomes in Wisconsin.

3D imaging services play a crucial role in the medical sector. Doctors and surgeons can gain important information and take informed decisions based on 3D images.